Furthermore, epigenetic alterations and differential expressions have been observed in other genes, such as those in the IL17 pathway, where differentially methylated CpG sites have been associated with MPNST progression [71]. This evidence concerns the gene IL17A and malignant peripheral nerve sheath tumor.